Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06405828 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Enhancing Access to Supportive Services for Women of Color With Metastatic Breast Cancer

Study acronym: ACCESS
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 1 year 1 month later Jul 31, 2026 → Sep 1, 2027
See other at-risk trials from Icahn School of Medicine at Mount Sinai

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Jul 31, 2026 to Sep 1, 2027
    • Study completion pushed from Nov 30, 2026 to Sep 1, 2027
    • Eligibility criteria expanded, about 9 words
    • Study description expanded, about 2 words
  2. Enrollment target: 60 to 67
    • Site contact updated
    v4
  3. Primary completion date: Jan 2025 to Jul 31, 2026v3 Show 4 more changesShow less
    • Study completion date: Jan 2025 to Nov 30, 2026
    • Start date: May 9, 2024 to May 1, 2024
    • Site contact updated
    • Eligibility criteria shortened, about 1 word
  4. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of May 2024 to May 9, 2024
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Black and Latina women experience disparities in supportive and palliative care access and outcomes. The goal of the proposed pilot study is to evaluate the feasibility and acceptability of a community navigator delivered supportive care intervention for historically underserved populations of women with metastatic breast cancer.
Trial Details
NCT Number NCT06405828
Lead Sponsor Icahn School of Medicine at Mount Sinai
Collaborators: National Cancer Institute (NCI)
Conditions
(from sponsor)		 Metastatic Breast Cancer, Stage IV Breast Cancer AJCC V7
Related terms Breast Neoplasms
Enrollment 67 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov